The mitochondrial protective mechanisms mediated by SGLT2i: from molecular basis to clinical implications

Jianing Chen1, Fengqi Wan2, Kaiyue Wu3

  • 1Children's Functional Examination Department, The Second Hospital of Lanzhou University, Lanzhou, China.

Insights

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) lower blood glucose and protect organs. These drugs improve mitochondrial function, which may explain their protective effects on the cardiovascular, renal, and nervous systems.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Cell Biology

Background:

  • Sodium-glucose cotransporter 2 inhibitors (SGLT2i) lower blood glucose by inhibiting renal glucose reabsorption.
  • SGLT2i demonstrate protective effects on cardiovascular, renal, and nervous systems, but the underlying mechanisms are not fully understood.
  • Mitochondria are crucial for cellular energy, redox balance, and calcium regulation, and are implicated in chronic disease progression.

Purpose of the Study:

  • To review the mitochondria-centered mechanisms underlying the protective effects of SGLT2 inhibitors.
  • To explore how SGLT2i modulate mitochondrial function and its impact on organ protection.
  • To discuss the therapeutic implications of these findings.

Main Methods:

  • Literature review focusing on studies investigating SGLT2 inhibitors and mitochondrial function.
  • Analysis of research on the role of mitochondria in cardiovascular, renal, and neurological diseases.
  • Synthesis of evidence linking SGLT2i-induced mitochondrial improvements to organ protection.

Main Results:

  • SGLT2i enhance mitochondrial quality control mechanisms.
  • SGLT2i modulate mitochondrial energy metabolism and strengthen antioxidant defenses.
  • SGLT2i contribute to maintaining mitochondrial calcium homeostasis.

Conclusions:

  • Mitochondrial improvements, including enhanced quality control, modulated metabolism, and preserved calcium homeostasis, are key mechanisms for SGLT2i organ protection.
  • Targeting mitochondrial function represents a promising therapeutic strategy for chronic diseases.
  • Further research into these mitochondria-centered effects could optimize SGLT2i utilization and uncover new therapeutic avenues.

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.1K
Secondary Active Transport01:32

Secondary Active Transport

One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme "pump" embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
9.3K
Secondary Active Transport01:55

Secondary Active Transport

One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme “pump” embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
136.8K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
16.7K
Glucose Absorption Into the Small Intestine01:26

Glucose Absorption Into the Small Intestine

Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
34.9K